Susquehanna International Group Ltd. Oramed Pharmaceuticals Inc. Transaction History

Susquehanna International Group Ltd.

  • $390 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 16, 2023
BUY
$1.93 - $13.1 $219,105 - $1.49 Million
113,526 New
113,526 $247,000
Q1 2022

May 16, 2022
SELL
$8.19 - $13.89 $110,884 - $188,056
-13,539 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$12.98 - $29.75 $175,736 - $402,785
13,539 New
13,539 $178,000

Others Institutions Holding ORMP

# of Institutions
63
Shares Held
7.4M
Call Options Held
4K
Put Options Held
2.1K
View Full List

About ORAMED PHARMACEUTICALS INC.

ORMP Quotes by TradingView
  • Ticker ORMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,100
  • Market Cap $90.9M
  • Description
  • Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...
More about ORMP
Track This Portfolio

Track Susquehanna International Group Ltd. Portfolio

Follow Susquehanna International Group Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email